188 related articles for article (PubMed ID: 37072512)
1. Senescent CD4
Amezcua-Guerra LM; Espinosa-Bautista F; Hopf-Estandía K; Valdivieso-Ruiz M; Coronel D; Robledo S; Ramos-Rosillo V; Del Rocío Martínez-Alvarado M; Patlán M; Páez A; Silveira LH; Tavera-Alonso C; Massó F; Soto-Fajardo C; Pineda C
Clin Rheumatol; 2023 Aug; 42(8):2181-2186. PubMed ID: 37072512
[TBL] [Abstract][Full Text] [Related]
2. An imbalance in the T-helper phenotypes displayed by senescent CD4
Lozada-Navarro AC; Castillo-Martínez D; Moreno-Ramírez M; Acosta-Peña G; Páez A; Massó F; Márquez-Velasco R; Amezcua-Guerra LM
Lupus; 2018 Nov; 27(13):2155-2160. PubMed ID: 30111238
[TBL] [Abstract][Full Text] [Related]
3. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.
Kanbay M; Huddam B; Azak A; Solak Y; Kadioglu GK; Kirbas I; Duranay M; Covic A; Johnson RJ
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1887-94. PubMed ID: 21784838
[TBL] [Abstract][Full Text] [Related]
4. Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia.
Takir M; Kostek O; Ozkok A; Elcioglu OC; Bakan A; Erek A; Mutlu HH; Telci O; Semerci A; Odabas AR; Afsar B; Smits G; ALanaspa M; Sharma S; Johnson RJ; Kanbay M
J Investig Med; 2015 Dec; 63(8):924-9. PubMed ID: 26571421
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction.
Shabir S; Smith H; Kaul B; Pachnio A; Jham S; Kuravi S; Ball S; Chand S; Moss P; Harper L; Borrows R
Am J Transplant; 2016 Apr; 16(4):1113-28. PubMed ID: 26603521
[TBL] [Abstract][Full Text] [Related]
6. Expanded peripheral CD4
Okba AM; Abd El Raouf Raafat M; Nazmy Farres M; Abd El Nour Melek N; Amin MM; Gendy NN
Hum Immunol; 2019 Sep; 80(9):748-754. PubMed ID: 30853362
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis.
Téo FH; de Oliveira RT; Mamoni RL; Ferreira MC; Nadruz W; Coelho OR; Fernandes Jde L; Blotta MH
Cell Immunol; 2013 Jan; 281(1):11-9. PubMed ID: 23416719
[TBL] [Abstract][Full Text] [Related]
8. Loss of CD28 within CD4
Escarra-Senmarti M; Bueno-Topete MR; Jave-Suarez LF; Gomez-Bañuelos E; Gutierrez-Franco J; Vega-Magaña N; Aguilar-Lemarroy A; Pereira-Suarez AL; Haramati J; Del Toro-Arreola S
Immunol Lett; 2017 Feb; 182():30-38. PubMed ID: 28087292
[TBL] [Abstract][Full Text] [Related]
9. The expression levels of transcription factors T-bet, GATA-3, RORγt and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance.
Lin ZW; Wu LX; Xie Y; Ou X; Tian PK; Liu XP; Min J; Wang J; Chen RF; Chen YJ; Liu C; Ye H; Ou QJ
Int J Med Sci; 2015; 12(1):7-16. PubMed ID: 25552913
[TBL] [Abstract][Full Text] [Related]
10. Expanded lung T-bet+RORγT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype.
Kaiser Y; Lepzien R; Kullberg S; Eklund A; Smed-Sörensen A; Grunewald J
Eur Respir J; 2016 Aug; 48(2):484-94. PubMed ID: 27230441
[TBL] [Abstract][Full Text] [Related]
11. Immunological role of CD4
ElAlfy MS; Adly AAM; Ebeid FSE; Eissa DS; Ismail EAR; Mohammed YH; Ahmed ME; Saad AS
Immunol Res; 2018 Aug; 66(4):480-490. PubMed ID: 29926339
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD4
El-Samahy MH; Tantawy AAG; Adly AAM; Habeeb NM; Ismail EAR; Hamed GM; Eladawy R
Pediatr Diabetes; 2017 Dec; 18(8):785-793. PubMed ID: 28102614
[TBL] [Abstract][Full Text] [Related]
13. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
[TBL] [Abstract][Full Text] [Related]
14. CD4
Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M
Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic CD4+CD28 null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease.
Yadav AK; Lal A; Jha V
Nephron Clin Pract; 2012; 120(4):c185-93. PubMed ID: 22907478
[TBL] [Abstract][Full Text] [Related]
16. Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics.
Pieper J; Johansson S; Snir O; Linton L; Rieck M; Buckner JH; Winqvist O; van Vollenhoven R; Malmström V
Scand J Immunol; 2014 Feb; 79(2):149-55. PubMed ID: 24313359
[TBL] [Abstract][Full Text] [Related]
17. Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease.
Hodge G; Mukaro V; Reynolds PN; Hodge S
Clin Exp Immunol; 2011 Oct; 166(1):94-102. PubMed ID: 21910726
[TBL] [Abstract][Full Text] [Related]
18. Correlation between CD4
Ruggio A; Pedicino D; Flego D; Vergallo R; Severino A; Lucci C; Niccoli G; Trani C; Burzotta F; Aurigemma C; Leone AM; Buffon A; D'Aiello A; Biasucci LM; Crea F; Liuzzo G
Int J Cardiol; 2019 Feb; 276():289-292. PubMed ID: 30217424
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of expanded CD4+CD28null T cells in patients with chronic hepatitis B.
Wang Y; Bai J; Li F; Wang H; Fu X; Zhao T; Xu W; Zhang J; Ni B; Wu Y
Immunol Invest; 2009; 38(5):434-46. PubMed ID: 19811419
[TBL] [Abstract][Full Text] [Related]
20. CD4
Dedeoglu B; Litjens NHR; Klepper M; Kraaijeveld R; Verschoor W; Baan CC; Betjes MGH
Am J Transplant; 2018 Feb; 18(2):341-350. PubMed ID: 28858434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
